\-\ Texto\\:\\ \ \(0\)\
\-\ patient\\ was\\ referred\\ immediately\\ to\\ maternal\\-fetal\\ medicine\\.\\ \\ interestingly\\,\\ this\\ patient\\ well\\ into\\ 3rd\\ trimester\\ continues\\ to\\ demonstrate\\ a\\ low\\ normal\\ afi\\ and\\ normal\\ chest\\ circumference\\.\ \(0\)\
\-\ bilaterally\\ markedly\\ enlarged\\,\\ hyperechoic\\ kidneys\\.\\ \\ the\\ amniotic\\ fluid\\ index\\ was\\ low\\ normal\\.\ \(0\)\
\-\ autosomal\\ recessive\\ polycystic\\ kidney\\ disease\ \(2\)\
\-\ arpckd\\ \\-\\ nephronophthisis\\ medullary\\-cystic\\ disease\\ complex\ \(0\)\
\-\ bilateral\\ replacement\\ of\\ the\\ kidneys\\ with\\ masses\\ such\\ as\\ bilateral\\ mesoblastic\\ nephromas\\ or\\ nephroblastomatosis\\ \\-\\ neither\\ of\\ which\\ are\\ classically\\ hyperechoic\ \(0\)\
\-\ 22y\\/o\\ female\\ with\\ intra\\ uterine\\ pregnancy\\ at\\ 22weeks\\ 5\\ days\\ presented\\ for\\ follow\\ up\\ of\\ routine\\ 2nd\\ trimester\\ ultrasound\\ done\\ 3\\ weeks\\ prior\\.\\ the\\ fetus\\ at\\ 19\\ weeks\\ was\\ seen\\ to\\ have\\ appearance\\ of\\ minimal\\ pelviectasis\\ bilaterally\\ as\\ well\\ as\\ mild\\ enlargement\\ of\\ both\\ kidneys\\,\\ and\\ this\\ follow\\ up\\ scan\\ was\\ scheduled\\.\ \(0\)\
\-\ most\\ in\\-utero\\ diagnosed\\ arpckd\\ is\\ in\\ a\\ setting\\ of\\ marked\\ oligohydramnios\\.\\ \\ as\\ a\\ result\\,\\ there\\ is\\ lack\\ of\\ lung\\ development\\ and\\ the\\ fetus\\ dies\\ shortly\\ after\\ delivery\\.\\ \\ as\\ this\\ fetus\\ is\\ demonstrating\\ atleast\\ some\\ maintanance\\ of\\ renal\\ function\\ \\/\\ urine\\ production\\,\\ preparation\\ for\\ this\\ infants\\ delivery\\ has\\ been\\ more\\ difficult\\ as\\ planning\\ is\\ needing\\ to\\ include\\ preparations\\ for\\ dialysis\\ and\\ renal\\ transplant\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ arpckd\\:\\ 0\\.08949764897427917\ \(0\)\
\-\ fetus\\:\\ 0\\.07594228975853914\ \(0\)\
\-\ kidneys\\:\\ 0\\.059889083777362344\ \(0\)\
\-\ trimester\\:\\ 0\\.0564205267608631\ \(0\)\
\-\ afi\\:\\ 0\\.044748824487139585\ \(0\)\
\-\ medullary\\-cystic\\:\\ 0\\.044748824487139585\ \(0\)\
\-\ nephromas\\:\\ 0\\.044748824487139585\ \(0\)\
\-\ 22weeks\\:\\ 0\\.044748824487139585\ \(0\)\
\-\ maintanance\\:\\ 0\\.044748824487139585\ \(0\)\
\-\ delivery\\:\\ 0\\.04451473731089527\ \(0\)\
\-\ hyperechoic\\:\\ 0\\.0433728288497106\ \(0\)\
\-\ nephronophthisis\\:\\ 0\\.04123031088023631\ \(0\)\
\-\ 22y\\/o\\:\\ 0\\.04123031088023631\ \(0\)\
\-\ atleast\\:\\ 0\\.04123031088023631\ \(0\)\
\-\ as\\:\\ 0\\.039367842819110495\ \(0\)\
\-\ maternal\\-fetal\\:\\ 0\\.03917211236192075\ \(0\)\
\-\ preparations\\:\\ 0\\.03917211236192075\ \(0\)\
\-\ dies\\:\\ 0\\.03771179727333303\ \(0\)\
\-\ in\\-utero\\:\\ 0\\.035653598755017474\ \(0\)\
\-\ needing\\:\\ 0\\.035653598755017474\ \(0\)\
\-\ pelviectasis\\:\\ 0\\.034871107994473016\ \(0\)\
\-\ oligohydramnios\\:\\ 0\\.034871107994473016\ \(0\)\
\-\ mesoblastic\\:\\ 0\\.034193283666429757\ \(0\)\
\-\ nephroblastomatosis\\:\\ 0\\.034193283666429757\ \(0\)\
\-\ preparation\\:\\ 0\\.03257676726481283\ \(0\)\
\-\ amniotic\\:\\ 0\\.030076886629798648\ \(0\)\
\-\ neither\\:\\ 0\\.029058253657909552\ \(0\)\
\-\ interestingly\\:\\ 0\\.028832610193082985\ \(0\)\
\-\ recessive\\:\\ 0\\.028832610193082985\ \(0\)\
\-\ bilaterally\\:\\ 0\\.02849446942663861\ \(0\)\
\-\ circumference\\:\\ 0\\.02801868811148309\ \(0\)\
\-\ intra\\:\\ 0\\.02801868811148309\ \(0\)\
\-\ planning\\:\\ 0\\.02801868811148309\ \(0\)\
\-\ follow\\:\\ 0\\.02756547687255263\ \(0\)\
\-\ dialysis\\:\\ 0\\.027156256452623203\ \(0\)\
\-\ production\\:\\ 0\\.026283920123046256\ \(0\)\
\-\ renal\\:\\ 0\\.026065741618863644\ \(0\)\
\-\ polycystic\\:\\ 0\\.025656438113060585\ \(0\)\
\-\ classically\\:\\ 0\\.02531409658617971\ \(0\)\
\-\ index\\:\\ 0\\.025204928031758576\ \(0\)\
\-\ infants\\:\\ 0\\.025204928031758576\ \(0\)\
\-\ autosomal\\:\\ 0\\.025098057934307652\ \(0\)\
\-\ shortly\\:\\ 0\\.024691749773528275\ \(0\)\
\-\ weeks\\:\\ 0\\.024622109207118256\ \(0\)\
\-\ low\\:\\ 0\\.024123533531638573\ \(0\)\
\-\ transplant\\:\\ 0\\.023965349552002017\ \(0\)\
\-\ up\\:\\ 0\\.02332839747263171\ \(0\)\
\-\ continues\\:\\ 0\\.02263355125521272\ \(0\)\
\-\ uterine\\:\\ 0\\.022257368655447633\ \(0\)\
\-\ setting\\:\\ 0\\.021907151033686463\ \(0\)\
\-\ scheduled\\:\\ 0\\.021851060494668267\ \(0\)\
\-\ 2nd\\:\\ 0\\.021632698133837346\ \(0\)\
\-\ immediately\\:\\ 0\\.021526941347528503\ \(0\)\
\-\ 3rd\\:\\ 0\\.021474877894903176\ \(0\)\
\-\ \\/\\:\\ 0\\.02142334301437517\ \(0\)\
\-\ replacement\\:\\ 0\\.021173236166625004\ \(0\)\
\-\ bilateral\\:\\ 0\\.021053987099639022\ \(0\)\
\-\ urine\\:\\ 0\\.02093487584638251\ \(0\)\
\-\ medicine\\:\\ 0\\.020575352736897166\ \(0\)\
\-\ markedly\\:\\ 0\\.02053215126650169\ \(0\)\
\-\ normal\\:\\ 0\\.020400189663945703\ \(0\)\
\-\ was\\:\\ 0\\.02006654867438958\ \(0\)\
\-\ 19\\:\\ 0\\.020001629953123587\ \(0\)\
\-\ lack\\:\\ 0\\.01973738446096088\ \(0\)\
\-\ well\\:\\ 0\\.019625187339783256\ \(0\)\
\-\ this\\:\\ 0\\.019515476412469705\ \(0\)\
\-\ difficult\\:\\ 0\\.01898652085651102\ \(0\)\
\-\ development\\:\\ 0\\.018892224483044343\ \(0\)\
\-\ demonstrating\\:\\ 0\\.018830319543481813\ \(0\)\
\-\ pregnancy\\:\\ 0\\.018649009479511865\ \(0\)\
\-\ \\-\\:\\ 0\\.018596228007191507\ \(0\)\
\-\ function\\:\\ 0\\.018388637426783185\ \(0\)\
\-\ done\\:\\ 0\\.017982329266003814\ \(0\)\
\-\ routine\\:\\ 0\\.017393130427157347\ \(0\)\
\-\ complex\\:\\ 0\\.017370004454894093\ \(0\)\
\-\ enlargement\\:\\ 0\\.017211007139518248\ \(0\)\
\-\ minimal\\:\\ 0\\.017078578529953287\ \(0\)\
\-\ marked\\:\\ 0\\.016928322338195464\ \(0\)\
\-\ result\\:\\ 0\\.016640528715471885\ \(0\)\
\-\ referred\\:\\ 0\\.016368179916018483\ \(0\)\
\-\ diagnosed\\:\\ 0\\.01595022922230967\ \(0\)\
\-\ kidney\\:\\ 0\\.015281134289593956\ \(0\)\
\-\ enlarged\\:\\ 0\\.01480010695626399\ \(0\)\
\-\ masses\\:\\ 0\\.014662905573584198\ \(0\)\
\-\ disease\\:\\ 0\\.014180076560565523\ \(0\)\
\-\ such\\:\\ 0\\.013560064923050012\ \(0\)\
\-\ days\\:\\ 0\\.01329479338158364\ \(0\)\
\-\ some\\:\\ 0\\.013172224638917557\ \(0\)\
\-\ ultrasound\\:\\ 0\\.012868642563483771\ \(0\)\
\-\ 5\\:\\ 0\\.01269116965707697\ \(0\)\
\-\ lung\\:\\ 0\\.012564259493597695\ \(0\)\
\-\ appearance\\:\\ 0\\.012405617140784982\ \(0\)\
\-\ fluid\\:\\ 0\\.01232811728225306\ \(0\)\
\-\ include\\:\\ 0\\.012168291817412621\ \(0\)\
\-\ scan\\:\\ 0\\.012143509951436439\ \(0\)\
\-\ presented\\:\\ 0\\.011824150431585833\ \(0\)\
\-\ been\\:\\ 0\\.011800989286619244\ \(0\)\
\-\ at\\:\\ 0\\.011753940637884598\ \(0\)\
\-\ mild\\:\\ 0\\.011422606365132674\ \(0\)\
\-\ is\\:\\ 0\\.011417071642329454\ \(0\)\
\-\ prior\\:\\ 0\\.011137628285291185\ \(0\)\
\-\ for\\:\\ 0\\.011103169776285003\ \(0\)\
\-\ both\\:\\ 0\\.01107715731312752\ \(0\)\
\-\ more\\:\\ 0\\.010848610707168357\ \(0\)\
\-\ chest\\:\\ 0\\.010379335025672683\ \(0\)\
\-\ into\\:\\ 0\\.010321453644465517\ \(0\)\
\-\ 3\\:\\ 0\\.010157236176175328\ \(0\)\
\-\ most\\:\\ 0\\.01001439158237602\ \(0\)\
\-\ demonstrate\\:\\ 0\\.009981990565142337\ \(0\)\
\-\ have\\:\\ 0\\.009393086692208587\ \(0\)\
\-\ after\\:\\ 0\\.008974625393955342\ \(0\)\
\-\ female\\:\\ 0\\.008917564829684433\ \(0\)\
\-\ patient\\:\\ 0\\.008696364780877035\ \(0\)\
\-\ to\\:\\ 0\\.008671433673969263\ \(0\)\
\-\ seen\\:\\ 0\\.008571713782069492\ \(0\)\
\-\ has\\:\\ 0\\.008145685129412578\ \(0\)\
\-\ which\\:\\ 0\\.008097180645901262\ \(0\)\
\-\ \\,\\:\\ 0\\.006870813845616431\ \(0\)\
\-\ there\\:\\ 0\\.006455408916065932\ \(0\)\
\-\ a\\:\\ 0\\.0060395908906385985\ \(0\)\
\-\ are\\:\\ 0\\.005913065342789856\ \(0\)\
\-\ or\\:\\ 0\\.005083871822150799\ \(0\)\
\-\ of\\:\\ 0\\.00473111881413151\ \(0\)\
\-\ and\\:\\ 0\\.003655005192532354\ \(0\)\
\-\ the\\:\\ 0\\.0028070920752005235\ \(0\)\
\-\ in\\:\\ 0\\.0021390722342144917\ \(0\)\
\-\ \\.\\:\\ 0\\.0016218062176452611\ \(0\)\
\-\ with\\:\\ 0\\.001187859655734921\ \(0\)\
